- Health Canada authorized Dexcom’s G7 15 Day Continuous Glucose Monitoring (CGM) System for adults with diabetes, offering up to 15.5 days of continuous glucose monitoring.
- Dexcom G7 15 Day is the longest-lasting and most accurate CGM authorized in Canada, featuring fewer sensor changes, real-time glucose readings, and direct Apple Watch connectivity.
- The CGM builds on Dexcom’s clinically proven technology to help lower HbA1c and increase time in range, while simplifying diabetes management.
- Although approved, Dexcom G7 15 Day is not yet commercially available in Canada, with launch details to be announced later.
Takeaways
Dexcom G7 15 Day’s Health Canada authorization sets up a step-change in CGM economics and adoption once launched, by extending wear to 15.5 days and offering top-tier accuracy and direct Apple Watch connectivity, which should increase patient uptake, improve adherence, and intensify competitive pressure on other CGMs and fingerstick testing across Canada’s adult diabetes market.
Source: Businesswire
